|
|
|
Applied and Environmental Microbiology, May 2003, p . 3020-3023, Vol . 69, No . 5 An Improved Cloning Vector for Construction of Gene Replacements in Listeria monocytogenes
Guojie Li1, Department of Microbiology, University of Hawaii, Honolulu, Hawaii 96822,1 Department of Food Science and Graduate Program in Genomic Sciences, North Carolina State University, Raleigh, North Carolina 27695-76242 Received 4 October 2002/ Accepted 10 February 2003
The construction of well-defined gene deletions is highly desirable for genetic studies of this pathogen . Unlike mutations mediated by transposon insertion or other insertion mutagenesis schemes, which can be accompanied by polar effects, deletions allow the precise evaluation of the loss of a specific genetic determinant . The construction of in-frame deletions and their application in the genetic study of L . monocytogenes was originally described by Camilli et al . (3) with the temperature-sensitive shuttle plasmid pKSV7 (13), which can be introduced into L . monocytogenes by transformation of protoplasts (3) or by electroporation (10) . Subsequent studies have also utilized pCON1, a plasmid with the genetic features of pKSV7 and, in addition, an origin of transfer element which allows it to be transferred from Escherichia coli into L . monocytogenes by conjugation (1) . To select for deletions and other allelic exchange mutants generated with these vectors, the recombinant plasmids with the cloned mutation of interest are first integrated into homologous regions of the L . monocytogenes genome following growth of the bacteria at the restrictive temperature (42°C) in the presence of an antibiotic (chloramphenicol), the resistance to which is vector borne . The strains containing the integration are repeatedly grown at permissive temperature (30°C) without chloramphenicol, and allelic exchanges mediated by a second crossover are identified by the loss of chloramphenicol resistance . However, identification of the final allelic exchange recombinants is often cumbersome because of the lack of positive selection . If the allelic exchange products harboring the mutation (e.g., deletion mutants) have any growth bias relative to the wild-type recombinants, which theoretically are expected to constitute 50% of the population, the desired mutants are often found to be a minute (1 to 2%) fraction of the chloramphenicol-sensitive recombinants and sometimes are not recovered at all . Thus, the need exists for plasmids with additional selection markers to facilitate the construction of such allelic exchange mutants . The construction and application of such a vector are described in this report . Plasmid pGF-EM was derived from plasmid pGF, a pCON1 derivative that has been generated in our laboratory for the purpose of generating green fluorescence protein (GFP) fusions in L . monocytogenes (9) . Plasmid pGF was generated by cloning a promoterless gfp with a putative ribosomal binding site and flanking multiple cloning sites in pCON1 (Fig . 1A) . On the pCON1 backbone, the plasmid harbors genes for ampicillin resistance (expressed in E . coli) and chloramphenicol resistance (expressed in Listeria) . An erythromycin resistance gene from Tn917, erm, was cloned into pGF, to generate pGF-EM . To amplify erm, we used primers ermA and ermB (with BamHI and KpnI sites, respectively) (Table 1), based on the Tn917 sequence (11) and the Tn917 derivative pLTV3 (2) as a template . The amplified erm fragment was directionally cloned in BamHI- and KpnI-digested pGF downstream of gfp and in the same transcriptional orientation as the latter . The erythromycin resistance gene erm was amplified so as to lack both a promoter and a terminator in order to avoid influencing expression of downstream genes . The steps involved in the construction of the plasmid are diagrammatically shown in Fig . 1A . Figure 1B shows the sequence and multiple cloning sites immediately upstream of gfp in pGF-EM (as well as pGF) . Especially useful is the NheI site immediately following the gfp start codon, as it is readily amenable to the construction of in-frame fusions to gfp .
To construct an in-frame deletion in the putative ftsH, we used the steps outlined in Fig . 2 . We first used primers P1 and P2 (Table 1 and Fig . 2) with L . monocytogenes strain 4b1 (10) DNA as a template to amplify a 694-bp fragment which includes 148 bp of the intergenic region immediately upstream of ftsH and the 5' portion of ftsH (546 bp) . The PCR product was digested by HindIII and NheI and ligated to HindIII- and NheI-digested pGF-EM to generate pGF-EM-FtsH1 . We then used primers P3 and P4 (Table 1 and Fig . 2) to amplify a 501-bp fragment corresponding to the genomic region downstream of ftsH . The resulting PCR product was digested with KpnI and EcoRI and ligated to KpnI- and EcoRI-digested pGF-EM-FtsH1 to generate pGF-EM-FtsH2 . The constructed deletion in pGF-EM-FtsH2 harbored the 5' portion of ftsH fused in frame to gfp and lacked codons 181 to 687 of the ftsH coding sequence .
Following conjugative transfer of pGF-EM-FtsH2, which harbors the ftsH deletion into L . monocytogenes as described above, the culture was transferred five to seven times in the presence of erythromycin following overnight growth in stationary cultures at the restrictive temperature (42°C) . During each transfer, the cultures were allowed to grow for 24 h in brain heart infusion broth (Difco) without shaking . Under these conditions we observed a substantial enrichment (90%) of the culture for erythromycin-resistant, chloramphenicol-sensitive recombinants . PCR analysis of four randomly chosen colonies (done as described above) confirmed that in these bacteria the wild-type ftsH gene was indeed replaced by the deleted version . The deletion was confirmed by Southern blotting, as described above (data not shown) . Thus, allelic replacements can be obtained by positive selection and in a single step, obviating the need to first bring about the integration of the plasmid into the chromosome . Overall, mutants were constructed in a substantially shorter time and with higher efficiency (90 versus 66%) than by the two-step method . The most attractive feature of pGF-EM is the presence of a drug resistance gene (erm) that allows direct selection for the allelic exchange products . In the absence of such selection, the desired products are often a small fraction of the chloramphenicol-sensitive population . In our experience with deletions of several genes in L . monocytogenes, yields were often ca . 2% or lower, and substantial time and expense were dedicated to screening derivatives that proved to harbor the wild-type sequence . The construction of pGF-EM is such that in the two-step method only the allelic exchange products would harbor the erm gene whereas the remainder (second homologous recombination products with the wild-type sequence) would be erythromycin sensitive . In the one-step process, the combination of restrictive temperature and erythromycin selects for double-crossover events that integrate the cloned deletion into the chromosome and result in the desired allelic exchange mutants . An additional useful feature of pGF-EM is the presence of the promoterless gfp gene and multiple cloning sites, especially the NheI site mentioned earlier, which facilitates cloning in frame with gfp . Thus, if the promoter region of the gene that harbors the deletion is retained, the resulting allelic exchange is actually a "deletion-fusion" construct that can provide indications of the transcriptional level of the gene of interest . In addition, the construction of chromosomal translational fusions of the entire coding sequence of the gene of interest with gfp can be facilitated by pGF-EM . The usefulness of GFP fusions for genetic studies of L . monocytogenes has been demonstrated (5) . The presence of GFP in constructs generated by pGF-EM can be monitored by fluorescence as well as by Western blotting analyses with commercially available antibodies (e.g., anti-GFP monoclonal antibody mAb11E5; QbioGene) . The gfp gene used in these studies was originally derived from pQBI63 (Qbiogene) and is a red-shifted mutant in which amino acid residues Phe64, Ser65, and Ile168 of the GFP from Aequorea victoria were changed to Leu64, Cys65, and Thr168, respectively . This red-shifted GFP was chosen for these studies because of its reported stability, high resistance to photobleaching, and good expression in other bacterial systems (N . Ruby, personal communication) . The presence of the gfp and erm genes in the constructs does not seem to affect cellular fitness under laboratory conditions . There were no noticeable differences between insertion mutants harboring these genes (obtained following the first crossover) and the parental wild-type strain in terms of colony size, cell shape, and growth rate (data not shown) . The recent availability of the genome sequence data of two strains of L . monocytogenes (6; http://www.tigr.org) will greatly facilitate the extensive functional analysis of the organism's genetic repertoire . The plasmid described here will be useful in such studies not only with L . monocytogenes but also with the closely related but nonpathogenic species Listeria innocua, whose genome has also been recently deciphered (6), and is expected to contribute to several studies of the virulence and adaptive physiology of the organism, currently pursued by ourselves and others . In addition, since the plasmid is a pKSV7 derivative, it can be used for genetic analysis of Bacillus subtilis, in which pKSV7 is known to replicate (13), and possibly other gram-positive bacteria as well .
Funding for this work was partially provided by the International Life Sciences Institute-North America and by USDA grant NRI 99-35201-8183 .
What Is Biofilter?,
What Is Cell Biology?,
What Is Molecular Biology?,
What Is Bioassay?,
What Is Listeria Monocytogenes?,
a,
Microorganism,
s,
Microorganisms,
o,
Bacteria,
n,
Bacterium,
r,
Microbe,
n,
Rhizobacterium,
i,
Streptococcal,
i,
Escherichia coli,
o,
Microorganisms,
r,
Salmonella,
r,
Neisseria,
n,
Bactericidal,
i,
Lactococci,
a,
Escherichia coli,
c,
Staphylococcus aureus,
r,
Yeasts,
s,
Yeasts,
e,
Fermentations,
a,
Listeriosis,
o,
Escherichia coli,
e,
Antibiotics,
i,
Bacteria,
r,
Salmonella,
i,
Prokaryotes,
s,
Activated sludge,
r,
Botulism
|
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||